Login
$GNE
$16.75 -$0.15 (0.89%) Close

$GNE SEC Filings

Filed On Filing
05 Oct 2026 8-K: Regulation FD Disclosure

On October 5, 2026, the slide presentation (the “Presentation”) attached hereto as Exhibit 99.1 will be provided to certain investors. The Presentation will also be available on the Registrant’s website at the following link: http://geni...

06 Aug 2026 FORM 10-Q
06 Aug 2026 8-K: Results of Operations and Financial Condition
05 Aug 2026 Form 4: Jonas Howard S, Director

Gave up 9,105 shares to cover exercise price or tax ($129K)

05 Aug 2026 Form 4: Goldin Avi, CFO

Gave up 5,116 shares to cover exercise price or tax ($72.3K)

05 Aug 2026 Form 4: Stein Michael M, CHIEF EXECUTIVE OFFICER

Gave up 21,079 shares to cover exercise price or tax ($298K)

10 Jul 2026 FORM S-8
11 Jun 2026 Form 4: Katsof Irwin, Director

Received 2,190 shares as a grant or award ($31.2K)

11 Jun 2026 Form 3: Katsof Irwin, Director

Holds 0 shares of Class B Common Stock, par value $.01 per share

11 Jun 2026 8-K: Submission of Matters to a Vote of Security Holders
15 May 2026 FORM 10-Q
14 May 2026 8-K: Results of Operations and Financial Condition
12 May 2026 FORM NT 10-Q
01 May 2026 FORM DEF 14A

CEO pay $1.4M, down 61%

01 May 2026 FORM 10-K
07 Apr 2026 8-K: Notice of Delisting or Failure to Satisfy a Listing Rule; Regulation FD Disclosure
26 Mar 2026 8-K: Other Events
19 Mar 2026 8-K: Results of Operations and Financial Condition
16 Mar 2026 FORM NT 10-K
12 Mar 2026 8-K: Non-Reliance on Previously Issued Financial Statements

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support